THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Clinical trials for THERAPY-RELATED ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new THERAPY-RELATED ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for THERAPY-RELATED ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Matching AML therapy to genetics and fitness boosts survival in seniors
Disease control CompletedThis study looked at whether tailoring chemotherapy for older adults (60+) with acute myeloid leukemia (AML) based on their genetic profile and overall health can improve outcomes. 75 participants received either standard intensive or milder therapy based on these factors. The go…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 17, 2026 07:07 UTC
-
New drug combo shows promise in Tough-to-Treat leukemia
Disease control CompletedThis early-phase study tested two drugs, pevonedistat and decitabine, together in 12 people with high-risk acute myeloid leukemia (AML). The main goal was to find the safest dose and understand side effects. Researchers also looked at whether the combination could help control th…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 07:04 UTC
-
New Two-Step transplant shows promise for tough blood cancers
Disease control CompletedThis study tested a two-step stem cell transplant for 62 people with high-risk blood cancers like leukemia and lymphoma. First, patients got low-dose chemotherapy and radiation to prepare the body. Then, they received donor immune cells followed by a stem cell transplant. The goa…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Real-World italian study tracks vyxeos liposomal in AML patients
Knowledge-focused CompletedThis study looked at 113 adults in Italy with certain types of acute myeloid leukemia (AML) who were treated with Vyxeos liposomal as part of their normal care. Researchers tracked how many patients achieved complete remission without signs of the disease after treatment. The goa…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Sponsor: Jazz Pharmaceuticals • Aim: Knowledge-focused
Last updated May 17, 2026 07:03 UTC